You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Johnson and Johnson
McKinsey
Boehringer Ingelheim
Dow

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018801


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 018801 describes STERILE WATER FOR INJECTION, which is a drug marketed by Fresenius Kabi Usa, Hospira, Medefil Inc, West-ward Pharms Int, B Braun, Baxter Hlthcare, Icu Medical Inc, and Taro, and is included in eleven NDAs. It is available from ten suppliers. Additional details are available on the STERILE WATER FOR INJECTION profile page.

The generic ingredient in STERILE WATER FOR INJECTION is sterile water for injection. There are one thousand and seventy-two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.
Summary for 018801
Tradename:STERILE WATER FOR INJECTION
Applicant:Hospira
Ingredient:sterile water for injection
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 018801
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
STERILE WATER FOR INJECTION sterile water for injection LIQUID;N/A 018801 NDA Hospira, Inc. 0409-4887 0409-4887-10 25 VIAL, PLASTIC in 1 TRAY (0409-4887-10) > 10 mL in 1 VIAL, PLASTIC (0409-4887-17)
STERILE WATER FOR INJECTION sterile water for injection LIQUID;N/A 018801 NDA Hospira, Inc. 0409-4887 0409-4887-20 25 VIAL, PLASTIC in 1 TRAY (0409-4887-20) > 20 mL in 1 VIAL, PLASTIC (0409-4887-23)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:LIQUID;N/AStrength100% (1ML)
Approval Date:Oct 27, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:LIQUID;N/AStrength100% (10ML)
Approval Date:Oct 27, 1982TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:LIQUID;N/AStrength100% (20ML)
Approval Date:Oct 27, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
AstraZeneca
McKinsey
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.